Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Dollarpeeon May 17, 2018 9:26pm

88 Views

Post# 28050018

RE:March 30, 2019

Are you real at all !! When you smell success, do you mourn? This is complete victory that we have been waiting for. As you have righly pasted the ESTIMATED DATES, They are simply estimated dates not the ACTUAL DATES.
Just watch the spike tomorrow..............

Sarbbatth wrote: Too early to jump on any conclusions, bought some but a word of caution to all, this will take some time to evolve from here on. Not a overnight jump expected to the moon.

Below are the official stats

Estimated Primary Completion Date :- September 30, 2018
Estimated Study Completion Date:- March 30, 2019

https://www.clinicaltrials.gov/ct2/show/results/NCT03053635?term=theralase